Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear protein 1, also known as NUPR1, is a small, highly conserved chromatin-binding transcription factor that is rapidly induced by various forms of cellular stress. It plays a critical role in converting stress signals into specific gene expression programs that enhance cell survival under adverse conditions. In the context of pancreatic cancer and other malignancies, NUPR1 is frequently upregulated and contributes to tumor development by promoting resistance to apoptosis and supporting adaptation to nutrient deprivation or other microenvironmental stresses. Loss or inhibition of NUPR1 sensitizes cells to apoptotic stimuli and impairs their ability to survive under metabolic or genotoxic stress. Beyond its role in cancer biology, NUPR1 has been implicated in processes such as autophagy regulation and DNA repair following double-strand breaks. Its activity links it with several disease states where cellular adaptation to stress is crucial for pathogenesis or progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear protein 1, transcriptional regulator (NUPR1).